EmilMdeGomaMD

Cardiology • Philadelphia, PA

Adult Congenital Heart Disease, Preventive Cardiology

Medical Director, Preventive Cardiology, Perelman School of Medicine at University of Pennsylvania

Join to view full profile

Dr. deGoma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. deGoma's full profile

Already have an account?

Office
3400 Civic Center Blvd
# Ast
Philadelphia, PA 19104
Phone+1 215-615-4949

Fax+1 215-614-0069

Education & Training

Hospital of the University of PennsylvaniaPost-Doctoral Fellowship, 2010 - 2011
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2007 - 2010
Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2006 - 2007
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2004 - 2006
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003
Harvard UniversityBA, Biochemical Sciences, Magna Cum Laude, 1972

Certifications & Licensure

MA State Medical License 2017 - 2025
PA State Medical License 2010 - 2024
CA State Medical License 2004 - 2011
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
AHA Population Science Poster Competition Winner 2006
Fellow (FACC) American College of Cardiology

Clinical Trials

Assessment Of Vascular Health After Niacin Therapy (AVANT) Start of enrollment: 2012 Mar 01
Completed
Not Applicable
Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Start of enrollment: 2016 Dec 01
Completed
Phase 2

Publications & Presentations

PubMed

209 citations
Beyond High-Density Lipoprotein Cholesterol Levels: Evaluating High-Density Lipoprotein Function as Influenced by Novel Therapeutic Approaches
Emil M. deGoma, Rolando L. deGoma, Daniel J. Rader
Journal of the American College of Cardiology. 2008-06-10
29 citations
Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.
Emil M. deGoma, Mat D. Davis, Richard L. Dunbar, Emile R. Mohler, Philip Greenland
Atherosclerosis. 2013-08-01
109 citations
Novel HDL-directed pharmacotherapeutic strategies
Emil M. deGoma, Daniel J. Rader
Nature Reviews. Cardiology. 2011-05-01

Journal Articles

Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis.
deGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ, Atherosclerosis 2012;224:274-9
Targeting high density lipoproteins in the prevention of cardiovascular disease.
Larach D, deGoma EM, Rader DJ, Curr Cardiol Rep
Approach to the Patient with Extremely Low HDL- Cholesterol.
Rader DJ, deGoma EM, J Clin Endocrinol Metab 2012;97:3399-407
The underappreciated impact of heart disease.
deGoma EM, Karlsberg RP, Judelson DR, Budoff MJ, Women’s Health Issues 2010;20:299-303
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese family.
deGoma EM, Wheeler MT, Marcovina S, Ashley EA, J Clin Lipidol 2010;4:543-7
Surgically corrected right-sided aortic arch.
deGoma EM, Wright CD, Pelikan PC, Leal JE, Karlsberg RP, J Am Coll Cardiol 2011;57:2375
Guidewire embolization and right ventricular perforation visualized by cardiac CT.
deGoma EM, Goldberg NJ. Karlsberg RP, J Cardiovasc Comput Tomogr 2011;5:61
HDL particle number: A better biomarker to quantify HDL?
deGoma EM, Rader DJ, J Am Coll Cardiol 2012;60:517-20
HDL-targeted therapies: Where do we go from here?
Rader DJ, deGoma EM, Lipid Spin
Join now to see all

Books/Book Chapters

Comprehensive Management of High Risk Cardiovascular Patients.
Chapter: Peripheral arterial disease
deGoma EM, Rockson SGEditors: Toth PP, Gotto AM, Jr.Informa Healthcare, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Penetrating Atherosclerotic Ulcer and Intramural Hematoma
deGoma EM, Moulik S, Rovno SEditors: ER Mohler III.Demos Medical Publishing, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Type A Acute Aortic Dissection
Shiran H, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Type B Acute Aortic Dissection
Shiran H, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Abdominal Aortic Aneurysm
Lilly SM, Moulik S, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Thoracic Aortic Aneurysm
Yuriditsky E, Rovno S, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
American College of Cardiology Self-Assessment Program 8.
Chapter: Atherosclerosis Risk Assessment
deGoma EM, Polk DMEditors: DM Polk, P.T. O’Gara.American College of Cardiology, Washington, D.C
American College of Cardiology Self-Assessment Program 8.
Chapter: Board Review Questions
deGoma EM, Polk DMEditors: DM Polk, P.T. O’Gara.American College of Cardiology, Washington, D.C
Join now to see all

Abstracts/Posters

Clinical significance of HDL-C levels among patients with LDL-C < 60 mg/dL.
deGoma EM, Leeper NJ, Heidenreich PA, AHA Scientific Sessions
Statin use in patients with low LDL-C is associated with improved survival.
Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA, AHA Scientific Sessions

Lectures

Subclinical atherosclerosis imaging.
Perelman School of Medicine at the University of Pennsylvania. Cardiology Grand Rounds. Philadelphia
Coronary artery calcium scanning for cardiovascular risk refinement.
Perelman School of Medicine at the University of Pennsylvania. Medicine Grand Rounds. Philadelphia